Molecule X LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Clinical Study to Describe Biological Safety and Pharmacokinetics of Tyrphostin (NCT05487781) | Molecule X LLC | 2022-05-24 |
Track Molecule X LLC automatically
Every clearance here is in the API, with alerts when new ones post.